0001641172-25-008983.txt : 20250507 0001641172-25-008983.hdr.sgml : 20250507 20250507103801 ACCESSION NUMBER: 0001641172-25-008983 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20250507 DATE AS OF CHANGE: 20250507 EFFECTIVENESS DATE: 20250507 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Inductive Bio, Inc. CENTRAL INDEX KEY: 0002065009 ORGANIZATION NAME: EIN: 873805764 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-545424 FILM NUMBER: 25919847 BUSINESS ADDRESS: STREET 1: 550 VANDERBILT AVE #730 CITY: BROOKLYN STATE: NY ZIP: 11238 BUSINESS PHONE: (646) 229-7139 MAIL ADDRESS: STREET 1: 550 VANDERBILT AVE #730 CITY: BROOKLYN STATE: NY ZIP: 11238 D 1 primary_doc.xml X0708 D LIVE 0002065009 Inductive Bio, Inc. 550 VANDERBILT AVE #730 BROOKLYN NY NEW YORK 11238 (646) 229-7139 DELAWARE Prospect Heights Research, Inc. None Corporation true 2021 Joshua Daniel Haimson 550 Vanderbilt Ave #730 Brooklyn NY NEW YORK 11238 Executive Officer Director Benjamin Edward Birnbaum 550 Vanderbilt Ave #730 Brooklyn NY NEW YORK 11238 Executive Officer Director Rohan Ganesh 550 Vanderbilt Ave #730 Brooklyn NY NEW YORK 11238 Director Other Technology Decline to Disclose 06b false 2025-03-21 false true false 0 25105347 25105347 0 false 10 0 0 0 true The Issuer will use the proceeds from the sale of the shares for product development and other general corporate purposes, including the payment of salaries and others fees to those listed in Item 3. true Inductive Bio, Inc. /s/ Joshua Haimson Joshua Haimson Chief Executive Officer 2025-05-07